Production (Stage)
Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -801.10K | -814.00K | -344.40K | -346.20K | -462.70K |
| Total Depreciation and Amortization | 21.10K | 21.50K | 24.60K | 24.70K | 44.70K |
| Total Amortization of Deferred Charges | 53.10K | 54.00K | 53.00K | 53.30K | 1.90K |
| Total Other Non-Cash Items | 595.50K | 605.10K | 43.50K | 43.70K | 114.30K |
| Change in Net Operating Assets | 101.80K | 103.50K | -51.10K | -51.40K | -250.90K |
| Cash from Operations | -29.50K | -29.90K | -274.40K | -275.80K | -552.80K |
| Capital Expenditure | -5.80K | -5.90K | -- | -- | -1.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -8.30K | -8.50K | 1.30K | 1.30K | -77.60K |
| Cash from Investing | -14.10K | -14.30K | 1.30K | 1.30K | -79.50K |
| Total Debt Issued | 18.50K | 18.50K | 36.00K | 36.00K | 0.00 |
| Total Debt Repaid | -14.50K | -14.50K | -14.50K | -14.50K | -49.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 943.50K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -96.50K |
| Cash from Financing | 5.10K | 5.20K | 27.10K | 27.30K | 991.30K |
| Foreign Exchange rate Adjustments | -15.40K | -15.60K | 6.90K | 7.00K | 12.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -53.80K | -54.70K | -239.10K | -240.30K | 371.40K |